Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


02.07.2018

1 AJR Am J Roentgenol
2 Am J Gastroenterol
1 Am J Pathol
2 Biochem Biophys Res Commun
1 BMC Cancer
2 BMC Gastroenterol
1 Dig Dis Sci
1 Eur Med J Hepatol
2 Eur Radiol
1 Gastroenterology
6 Indian J Gastroenterol
8 J Clin Oncol
1 J Comput Assist Tomogr
1 J Gastroenterol
2 J Gastroenterol Hepatol
2 J Hepatol
1 J Pediatr
4 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. ELSAYES KM, Chernyak V, Morshid AI, Tang A, et al
    Spectrum of Pitfalls, Pseudolesions, and Potential Misdiagnoses in Cirrhosis.
    AJR Am J Roentgenol. 2018;211:87-96.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  2. HUSSEN N, Zhu L, Tetangco E, Ellison S, et al
    Hepatoptosis in a Patient with Alcoholic Hepatitis.
    Am J Gastroenterol. 2018 Jun 29. pii: 10.1038/s41395-018-0182.
    PubMed     Text format    

  3. VIOLI F, Talerico G, Basili S
    A Closer Look at Platelet Count and Prediction of Bleeding in Cirrhotic Patients.
    Am J Gastroenterol. 2018 Jun 29. pii: 10.1038/s41395-018-0191.
    PubMed     Text format    


    Am J Pathol

  4. TSAI HC, Li TH, Huang CC, Huang SF, et al
    Beneficial Effects of the Peroxisome Proliferator-Activated Receptor alpha/gamma Agonist Aleglitazar on Progressive Hepatic and Splanchnic Abnormalities in Cirrhotic Rats with Portal Hypertension.
    Am J Pathol. 2018;188:1608-1624.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  5. HUANG Y, Chen G, Wang Y, He R, et al
    Inhibition of microRNA-16 facilitates the paclitaxel resistance by targeting IKBKB via NF-kappaB signaling pathway in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2018 Jun 20. pii: S0006-291X(18)31425.
    PubMed     Text format     Abstract available

  6. KIMURA H, Matsunaga N, Kakimto K, Watanabe M, et al
    Epithelial cell adhesion molecule expression in hepatic stem/progenitor cells is controlled by the molecular clock system.
    Biochem Biophys Res Commun. 2018 Jun 26. pii: S0006-291X(18)31429.
    PubMed     Text format     Abstract available


    BMC Cancer

  7. MURAKAMI Y, Sugiyama K, Ebinuma H, Nakamoto N, et al
    Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells.
    BMC Cancer. 2018;18:680.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  8. MOLEDINA SM, Komba E
    Risk factors for mortality among patients admitted with upper gastrointestinal bleeding at a tertiary hospital: a prospective cohort study.
    BMC Gastroenterol. 2017;17:165.
    PubMed     Text format     Abstract available

  9. WONGJARUPONG N, Assavapongpaiboon B, Susantitaphong P, Cheungpasitporn W, et al
    Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis.
    BMC Gastroenterol. 2017;17:149.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  10. ZHANG S, Gong Y, Xiao J, Chai Y, et al
    A COL1A1 Promoter-Controlled Expression of TGF-beta Soluble Receptor Inhibits Hepatic Fibrosis Without Triggering Autoimmune Responses.
    Dig Dis Sci. 2018 Jun 23. pii: 10.1007/s10620-018-5168.
    PubMed     Text format     Abstract available


    Eur Med J Hepatol

  11. GRUNHUT J, Wang W, Aykut B, Gakhal I, et al
    Macrophages in Nonalcoholic Steatohepatitis: Friend or Foe?
    Eur Med J Hepatol. 2018;6:100-109.
    PubMed     Text format     Abstract available


    Eur Radiol

  12. REFAAT R, Basha MAA, Hassan MS, Hussein RS, et al
    Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.
    Eur Radiol. 2018 Jun 12. pii: 10.1007/s00330-018-5425.
    PubMed     Text format     Abstract available

  13. JEON SK, Joo I, Lee DH, Lee SM, et al
    Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging.
    Eur Radiol. 2018 Jun 28. pii: 10.1007/s00330-018-5605.
    PubMed     Text format     Abstract available


    Gastroenterology

  14. ESTEBAN R, Pineda JA, Calleja JL, Casado M, et al
    Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With HCV genotype 3 Infection and Cirrhosis.
    Gastroenterology. 2018 Jun 26. pii: S0016-5085(18)34684.
    PubMed     Text format     Abstract available


    Indian J Gastroenterol

  15. KILAMBI R, Singh AN, Madhusudhan KS, Pal S, et al
    Portal hypertension and hypersplenism in extrahepatic portal venous obstruction: Are they related?
    Indian J Gastroenterol. 2018 Jun 23. pii: 10.1007/s12664-018-0864.
    PubMed     Text format     Abstract available

  16. JOSHI A, Falodia S, Kumar N, Gupta P, et al
    Prevalence of celiac disease among pediatric patients with cryptogenic cirrhosis and effect of gluten-free-diet.
    Indian J Gastroenterol. 2018 Jun 13. pii: 10.1007/s12664-018-0857.
    PubMed     Text format     Abstract available

  17. PAMECHA V, Borle DP, Kumar S, Bharathy KGS, et al
    Deceased donor liver transplant: Experience from a public sector hospital in India.
    Indian J Gastroenterol. 2018;37:18-24.
    PubMed     Text format     Abstract available

  18. MEHROTRA S, Mehta N, Rao PS, Lalwani S, et al
    Live donor liver transplantation for acute liver failure: A single center experience.
    Indian J Gastroenterol. 2018;37:25-30.
    PubMed     Text format     Abstract available

  19. SONIKA U, Jadaun S, Ranjan G, Rout G, et al
    Alcohol-related acute-on-chronic liver failure-Comparison of various prognostic scores in predicting outcome.
    Indian J Gastroenterol. 2018;37:50-57.
    PubMed     Text format     Abstract available

  20. PHILIPS CA, Paramaguru R, Joy AK, Antony KL, et al
    Clinical outcomes, histopathological patterns, and chemical analysis of Ayurveda and herbal medicine associated with severe liver injury-A single-center experience from southern India.
    Indian J Gastroenterol. 2018;37:9-17.
    PubMed     Text format     Abstract available


    J Clin Oncol

  21. SMITH GL, Das P, Herman JM, Koay EJ, et al
    Comparing Ablative Modalities for Hepatocellular Carcinoma: Cautions in Interpreting Big Data.
    J Clin Oncol. 2018 Jun 26:JCO2018785428. doi: 10.1200/JCO.2018.78.5428.
    PubMed     Text format    

  22. OLSEN JR, Murphy JD, Hallemeier CL, Apisarnthanarax S, et al
    Cross-Modality Comparisons Between Radiofrequency Ablation and Stereotactic Body Radiotherapy for Treatment of Hepatocellular Carcinoma: Limitations of the National Cancer Database.
    J Clin Oncol. 2018 Jun 26:JCO2018782904. doi: 10.1200/JCO.2018.78.2904.
    PubMed     Text format    

  23. SANUKI N, Takeda A
    Are Head-to-Head Comparisons Between Radiofrequency Ablation and Stereotactic Body Radiotherapy Really Necessary for Localized Hepatocellular Carcinoma?
    J Clin Oncol. 2018 Jun 26:JCO2018782805. doi: 10.1200/JCO.2018.78.2805.
    PubMed     Text format    

  24. KIM N, Seong J
    What Role Does Locally Ablative Stereotactic Body Radiotherapy Play Versus Radiofrequency Ablation in Localized Hepatocellular Carcinoma?
    J Clin Oncol. 2018 Jun 26:JCO2018781740. doi: 10.1200/JCO.2018.78.1740.
    PubMed     Text format    

  25. WAHL DR, Schipper MJ, Parikh ND, Owen D, et al
    Casual Causality: Does Radiofrequency Ablation Really Prolong Survival After Treatment of Localized Hepatocellular Carcinoma?
    J Clin Oncol. 2018 Jun 26:JCO2018780882. doi: 10.1200/JCO.2018.78.0882.
    PubMed     Text format    

  26. OHRI N, Kabarriti R, Kaubisch A, Guha C, et al
    Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: Caution When Interpreting Observational Data.
    J Clin Oncol. 2018 Jun 26:JCO2018780122. doi: 10.1200/JCO.2018.78.0122.
    PubMed     Text format    

  27. FIORENTINO A, Alongi F
    Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: No Way Out Without a Randomized Trial?
    J Clin Oncol. 2018 Jun 26:JCO2018781005. doi: 10.1200/JCO.2018.78.1005.
    PubMed     Text format    

  28. SHINDE A, Jones BL, Chen YJ, Amini A, et al
    Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma: Does Radiation Dose Make a Difference?
    J Clin Oncol. 2018 Jun 26:JCO2018786012. doi: 10.1200/JCO.2018.78.6012.
    PubMed     Text format    


    J Comput Assist Tomogr

  29. VARGHESE J, Bergson J, Yaipen O
    Intrahepatic Splenosis: Incidental Liver Lesion after Splenectomy.
    J Comput Assist Tomogr. 2018 Jun 28. doi: 10.1097/RCT.0000000000000762.
    PubMed     Text format     Abstract available


    J Gastroenterol

  30. KIM TJ, Sinn DH, Min YW, Son HJ, et al
    A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease.
    J Gastroenterol. 2017 Apr 5. doi: 10.1007/s00535-017-1337.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  31. PAPALUCA T, Gow P
    Terlipressin: Current and emerging indications in chronic liver disease.
    J Gastroenterol Hepatol. 2018;33:591-598.
    PubMed     Text format     Abstract available

  32. ABE K, Takahashi A, Imaizumi H, Hayashi M, et al
    Utility of magnetic resonance elastography for predicting ascites in patients with chronic liver disease.
    J Gastroenterol Hepatol. 2018;33:733-740.
    PubMed     Text format     Abstract available


    J Hepatol

  33. QIN JJ, Mao W, Wang X, Sun P, et al
    Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1.
    J Hepatol. 2018 Jun 26. pii: S0168-8278(18)32167.
    PubMed     Text format     Abstract available

  34. FUHRMANN V, Krowka M
    Hepatopulmonary syndrome.
    J Hepatol. 2018 Jun 27. pii: S0168-8278(18)30007.
    PubMed     Text format    


    J Pediatr

  35. GRAMMATIKOPOULOS T, Deheragoda M, Strautnieks S, Neves Souza L, et al
    Reduced Hepatocellular Expression of Canalicular Transport Proteins in Infants with Neonatal Cholestasis and Congenital Hypopituitarism.
    J Pediatr. 2018 Jun 20. pii: S0022-3476(18)30656.
    PubMed     Text format     Abstract available


    PLoS One

  36. HOF J, Joosten HJ, Havenga K, de Jong KP, et al
    Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer.
    PLoS One. 2018;13:e0193385.
    PubMed     Text format     Abstract available

  37. MAYR U, Karsten E, Lahmer T, Rasch S, et al
    Impact of large volume paracentesis on respiratory parameters including transpulmonary pressure and on transpulmonary thermodilution derived hemodynamics: A prospective study.
    PLoS One. 2018;13:e0193654.
    PubMed     Text format     Abstract available

  38. ZEKRI AN, El-Sisi ER, Youssef ASE, Kamel MM, et al
    MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.
    PLoS One. 2018;13:e0193709.
    PubMed     Text format     Abstract available

  39. LUO L, Aubrecht J, Li D, Warner RL, et al
    Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans.
    PLoS One. 2018;13:e0193824.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  40. YAO K, Peng C, Zhang Y, Zykova TA, et al
    RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth.
    Proc Natl Acad Sci U S A. 2017 Nov 13. pii: 201710756.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: